Effectiveness of left atrial appendage exclusion procedures to reduce the risk of stroke: A systematic review of the evidence

Circulation: Cardiovascular Quality and Outcomes

Volumn 9, Issue 4, 2016, Pages 395-405

  Noelck, North ^a,b   Papak, Joel ^a,b   Freeman, Michele ^a   Paynter, Robin ^a   Low, Allison ^a   Motu'apuaka, Makalapua ^a   Kondo, Karli ^a   Kansagara, Devan ^a,b  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

anticoagulants; atrial appendage; atrial fibrillation; hemorrhage; stroke

Indexed keywords

WARFARIN;

ANTICOAGULANT THERAPY; ATRIAL FIBRILLATION; BLEEDING; CARDIOEMBOLIC STROKE; COCHRANE LIBRARY; COMPARATIVE EFFECTIVENESS; EMBASE; HEART ATRIUM APPENDAGE; HEART SURGERY; HUMAN; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; LEFT ATRIAL APPENDAGE CLOSURE DEVICE; LEFT ATRIAL APPENDAGE EXCLUSION PROCEDURE; LONG TERM CARE; MEDLINE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PERICARDIAL EFFUSION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; AGED; DEVICES; EVIDENCE BASED MEDICINE; FEMALE; HEART CATHETERIZATION; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; RISK ASSESSMENT; RISK FACTOR; STROKE; TIME FACTOR; TREATMENT OUTCOME;

AGED; ATRIAL APPENDAGE; ATRIAL FIBRILLATION; CARDIAC CATHETERIZATION; CARDIAC SURGICAL PROCEDURES; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS; STROKE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84979261587     PISSN: 19417713     EISSN: 19417705     Source Type: Journal    
DOI: 10.1161/CIRCOUTCOMES.115.002539     Document Type: Review

References (46)

1. January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, Conti JB, Ellinor PT, Ezekowitz MD, Field ME, Murray KT, Sacco RL, Stevenson WG, Tchou PJ, Tracy CM, Yancy CW, ACC/AHA Task Force Members 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation 2014 130 2071 2104. doi: 10.1161/CIR.0000000000000040
2. Arboix A, Alió J, Cardioembolic stroke: clinical features, specific cardiac disorders and prognosis. Curr Cardiol Rev 2010 6 150 161. doi: 10.2174/157340310791658730
3. Blackshear JL, Odell JA, Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg 1996 61 755 759. doi: 10.1016/0003-4975(95)00887-X
4. Manning WJ, Silverman DI, Gordon SP, Krumholz HM, Douglas PS, Cardioversion from atrial fibrillation without prolonged anticoagulation with use of transesophageal echocardiography to exclude the presence of atrial thrombi. N Engl J Med 1993 328 750 755. doi: 10.1056/NEJM199303183281102
5. Kansagara D, Noelck N, Papak J, Freeman M, Low A, Motu'apuaka M, Kondo K, Paynter R, The effectiveness of procedures to remove or occlude the left atrial appendage. Prospero 2015:Crd42015016685. http://www.Crd.York.Ac.Uk/prospero/display-record.Asp?Id=crd42015016685. Accessed May 31, 2016
6. Sampson M, McGowan J, Lefebvre C, Moher D, Grimshaw J, Press: Peer Review of Electronic Search Strategies 2008 Ottawa, Canada Canadian Agency for Drugs and Technologies in Health
7. Relevo R, Paynter R, Peer Review of Search Strategies 2012 Rockville, MD: Agency for Healthcare Research and Quality (publication no. 12-ehc068-ef)
8. Higgins JPT, Altman DG, Chapter 8: Assessing risk of bias in included studies. In: Cochrane Handbook for Systematic Reviews of Interventions 2008 John Wiley & Sons, Hoboken, NJ: The cochrane collaboration. http://handbook.cochrane.org. Accessed May 31, 2016
9. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P, The newcastle-ottawa scale (nos) for assessing the quality of nonrandomized studies in meta-Analyses. Http://www.Ohri.Ca/programs/clinical-epidemiology/oxford.Asp. Accessed May 31, 2016
10. Berkman ND, Lohr KN, Ansari M, McDonagh M, Balk E, Whitlock E, Reston J, Bass E, Butler M, Gartlehner G, Hartling L, Kane R, McPheeters M, Morgan L, Morton SC, Viswanathan M, Sista P, Chang S, Grading the Strength of a Body of Evidence When Assessing Health Care Interventions for the Effective Health Care Program of the Agency for Healthcare Research and Quality: An Update. Methods Guide for Comparative Effectiveness Reviews (Prepared by the RTI-UNC Evidence-Based Practice Center Under Contract no. 290-2007-10056-i). Ahrq publication no. 13(14)-ehc130-ef 2013 Rockville, MD Agency for Healthcare Research and Quality. http://www.Effectivehealthcare.Ahrq.Gov/ehc/products/457/1752/methods-guidance-grading-evidence-131118.Pdf. Accessed May 31, 2016
11. Holmes DR Jr, Kar S, Price MJ, Whisenant B, Sievert H, Doshi SK, Huber K, Reddy VY, Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-Term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol 2014 64 1 12. doi: 10.1016/j.jacc.2014.04.029
12. Alli O, Doshi S, Kar S, Reddy V, Sievert H, Mullin C, Swarup V, Whisenant B, Holmes D Jr, Quality of life assessment in the randomized PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) trial of patients at risk for stroke with nonvalvular atrial fibrillation. J Am Coll Cardiol 2013 61 1790 1798. doi: 10.1016/j.jacc.2013.01.061
13. Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, Mullin CM, Sick P, PROTECT AF Investigators Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet 2009 374 534 542. doi: 10.1016/S0140-6736(09)61343-X
14. Reddy VY, Doshi SK, Sievert H, Buchbinder M, Neuzil P, Huber K, Halperin JL, Holmes D, PROTECT AF Investigators Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial. Circulation 2013 127 720 729. doi: 10.1161/CIRCULATIONAHA.112.114389
15. Bartus K, Han FT, Bednarek J, Myc J, Kapelak B, Sadowski J, Lelakowski J, Bartus S, Yakubov SJ, Lee RJ, Percutaneous left atrial appendage suture ligation using the LARIAT device in patients with atrial fibrillation: initial clinical experience. J Am Coll Cardiol 2013 62 108 118. doi: 10.1016/j.jacc.2012.06.046
16. Bayard YL, Omran H, Neuzil P, Thuesen L, Pichler M, Rowland E, Ramondo A, Ruzyllo W, Budts W, Montalescot G, Brugada P, Serruys PW, Vahanian A, Piéchaud JF, Bartorelli A, Marco J, Probst P, Kuck KH, Ostermayer SH, Büscheck F, Fischer E, Leetz M, Sievert H, PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) for prevention of cardioembolic stroke in non-Anticoagulation eligible atrial fibrillation patients: results from the European PLAATO study. EuroIntervention 2010 6 220 226
17. Block PC, Burstein S, Casale PN, Kramer PH, Teirstein P, Williams DO, Reisman M, Percutaneous left atrial appendage occlusion for patients in atrial fibrillation suboptimal for warfarin therapy: 5-year results of the PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) Study. JACC Cardiovasc Interv 2009 2 594 600. doi: 10.1016/j.jcin.2009.05.005
18. Reddy VY, Holmes D, Doshi SK, Neuzil P, Kar S, Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry. Circulation 2011 123 417 424. doi: 10.1161/CIRCULATIONAHA.110.976449
19. Gangireddy SR, Halperin JL, Fuster V, Reddy VY, Percutaneous left atrial appendage closure for stroke prevention in patients with atrial fibrillation: an assessment of net clinical benefit. Eur Heart J 2012 33 2700 2708. doi: 10.1093/eurheartj/ehs292
20. Gafoor S, Franke J, Bertog S, Boehm P, Heuer L, Gonzaga M, Bauer J, Braut A, Lam S, Vaskelyte L, Hofmann I, Sievert H, Left atrial appendage occlusion in octogenarians: short-Term and 1-year follow-up. Catheter Cardiovasc Interv 2014 83 805 810. doi: 10.1002/ccd.25297
21. Matsuo Y, Sandri M, Mangner N, Majunke N, Dähnert I, Schuler G, Kurabayashi M, Möbius-Winkler S, Interventional closure of the left atrial appendage for stroke prevention. Circ J 2014 78 619 624
22. Nietlispach F, Gloekler S, Krause R, Shakir S, Schmid M, Khattab AA, Wenaweser P, Windecker S, Meier B, Amplatzer left atrial appendage occlusion: single center 10-year experience. Catheter Cardiovasc Interv 2013 82 283 289. doi: 10.1002/ccd.24872.
23. Ostermayer SH, Reisman M, Kramer PH, Matthews RV, Gray WA, Block PC, Omran H, Bartorelli AL, Della Bella P, Di Mario C, Pappone C, Casale PN, Moses JW, Poppas A, Williams DO, Meier B, Skanes A, Teirstein PS, Lesh MD, Nakai T, Bayard Y, Billinger K, Trepels T, Krumsdorf U, Sievert H, Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: results from the international multi-center feasibility trials. J Am Coll Cardiol 2005 46 9 14. doi: 10.1016/j.jacc.2005.03.042
24. Park JW, Leithäuser B, Gerk U, Vrsansky M, Jung F, Percutaneous left atrial appendage transcatheter occlusion (PLAATO) for stroke prevention in atrial fibrillation: 2-year outcomes. J Invasive Cardiol 2009 21 446 450
25. Price MJ, Gibson DN, Yakubov SJ, Schultz JC, Di Biase L, Natale A, Burkhardt JD, Pershad A, Byrne TJ, Gidney B, Aragon JR, Goldstein J, Moulton K, Patel T, Knight B, Lin AC, Valderrábano M, Early safety and efficacy of percutaneous left atrial appendage suture ligation: results from the US transcatheter LAA ligation consortium. J Am Coll Cardiol 2014 64 565 572. doi: 10.1016/j.jacc.2014.03.057
26. Reddy VY, Möbius-Winkler S, Miller MA, Neuzil P, Schuler G, Wiebe J, Sick P, Sievert H, Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology). J Am Coll Cardiol 2013 61 2551 2556. doi: 10.1016/j.jacc.2013.03.035
27. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ, Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 2001 285 2864 2870
28. Healey JS, Crystal E, Lamy A, Teoh K, Semelhago L, Hohnloser SH, Cybulsky I, Abouzahr L, Sawchuck C, Carroll S, Morillo C, Kleine P, Chu V, Lonn E, Connolly SJ, Left Atrial Appendage Occlusion Study (LAAOS): results of a randomized controlled pilot study of left atrial appendage occlusion during coronary bypass surgery in patients at risk for stroke. Am Heart J 2005 150 288 293. doi: 10.1016/j.ahj.2004.09.054
29. Nagpal AD, Torracca L, Fumero A, Denti P, Cioni M, Alfieri O, Concurrent prophylactic left atrial appendage exclusion: results from a randomized controlled trial pilot study. Eur J Cardiothorac Surg 2009 36 553 557. doi: 10.1016/j.ejcts.2009.03.024
30. Whitlock RP, Vincent J, Blackall MH, Hirsh J, Fremes S, Novick R, Devereaux PJ, Teoh K, Lamy A, Connolly SJ, Yusuf S, Carrier M, Healey JS, Left Atrial Appendage Occlusion Study II (LAAOS II). Can J Cardiol 2013 29 1443 1447. doi: 10.1016/j.cjca.2013.06.015
31. Kanderian AS, Gillinov AM, Pettersson GB, Blackstone E, Klein AL, Success of surgical left atrial appendage closure: assessment by transesophageal echocardiography. J Am Coll Cardiol 2008 52 924 929. doi: 10.1016/j.jacc.2008.03.067
32. Kim R, Baumgartner N, Clements J, Routine left atrial appendage ligation during cardiac surgery may prevent postoperative atrial fibrillation-related cerebrovascular accident. J Thorac Cardiovasc Surg 2013 145 582 589. doi: 10.1016/j.jtcvs.2012.10.016
33. Lee CH, Kim JB, Jung SH, Choo SJ, Chung CH, Lee JW, Left atrial appendage resection versus preservation during the surgical ablation of atrial fibrillation. Ann Thorac Surg 2014 97 124 132. doi: 10.1016/j.athoracsur.2013.07.073
34. Muhammad MI, Role of video-Assisted thoracoscopy in the management of stroke. Asian Cardiovasc Thorac Ann 2014 22 155 159. doi: 10.1177/0218492312474656
35. Connolly SJ, Pogue J, Hart RG, Hohnloser SH, Pfeffer M, Chrolavicius S, Yusuf S, Effect of clopidogrel added to aspirin in patients with atrial fibrillation. N Engl J Med 2009 360 2066 2078
36. Active Writing Group of the ACTIVE Investigators Connolly S, Pogue J, Hart R, Pfeffer M, Hohnloser S, Chrolavicius S, Pfeffer M, Hohnloser S, Yusuf S, Active Writing Group of the ACTIVE Investigators Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (active w): a randomised controlled trial. Lancet 2006 367 1903 1912
37. Chatterjee S, Herrmann HC, Wilensky RL, Hirshfeld J, McCormick D, Frankel DS, Yeh RW, Armstrong EJ, Kumbhani DJ, Giri J, Safety and Procedural Success of Left Atrial Appendage Exclusion With the Lariat Device: A Systematic Review of Published Reports and Analytic Review of the FDA MAUDE Database. JAMA Intern Med 2015 175 1104 1109. doi: 10.1001/jamainternmed.2015.1513
38. Bajaj NS, Parashar A, Agarwal S, Sodhi N, Poddar KL, Garg A, Tuzcu EM, Kapadia SR, Percutaneous left atrial appendage occlusion for stroke prophylaxis in nonvalvular atrial fibrillation: a systematic review and analysis of observational studies. JACC Cardiovasc Interv 2014 7 296 304. doi: 10.1016/j.jcin.2013.11.010
39. Munkholm-Larsen S, Cao C, Yan TD, Pehrson S, Dixen U, Percutaneous atrial appendage occlusion for stroke prevention in patients with atrial fibrillation: a systematic review. Heart 2012 98 900 907. doi: 10.1136/heartjnl-2011-301256
40. Bode WD, Patel N, Gehi AK, Left atrial appendage occlusion for prevention of stroke in non-valvular atrial fibrillation: a meta-Analysis. Circulation 2014 130 A11584
41. Holmes DR Jr, Doshi SK, Kar S, Price MJ, Sanchez JM, Sievert H, Valderrabano M, Reddy VY, Left atrial appendage closure as an alternative to warfarin for stroke prevention in atrial fibrillation: a patient-level meta-Analysis. J Am Coll Cardiol 2015 65 2614 2623. doi: 10.1016/j.jacc.2015.04.025
42. Moher D, Pham B, Lawson ML, Klassen TP, The inclusion of reports of randomised trials published in languages other than English in systematic reviews. Health Technol Assess 2003 7 1 90
43. Whitlock R, Connolly S, Left atrial appendage occlusion study III. Population health research institute/mcmaster university. Clinicaltrials.Gov identifier: Nct01561651. https://clinicaltrials.gov/show/Nct01561651. Accessed May 31, 2016
44. Lifetech Scientific (Shenzhen) Co. Ltd. Safety and efficacy study of Lambre LAA closure device for treating af patients who cannot take warfarin. Clinicaltrials.Gov identifier: Nct02029014. https://clinicaltrials.gov/show/Nct02029014. Accessed May 31, 2016
45. Brachmann J, Occlutech International AB Prospective, non-randomized, safety and efficacy study of a new occluder design for minimally invasive closure of the left atrial appendage (LAA) in patients with atrial fibrillation (OLAAC). Clinicaltrials.Gov identifier: Nct02105584. https://clinicaltrials.gov/show/Nct02105584. Accessed May 31, 2016
46. Osmancik P, Charles University, Czech Republic Ministry of Health Left Atrial Appendage Closure vs. Novel Anticoagulation Agents in Atrial Fibrillation (PRAGUE-17). ClinicalTrials.gov Identifier: NCT02426944. https://clinicaltrials.gov/show/NCT02426944. Accessed May 31, 2016